Analyst Ratings January 28, 2026

American Airlines Q4 Results Miss Estimates as Government Shutdown Cuts Revenue

EPS and unit metrics fall short; premium products and management guidance provide limited bright spots amid margin pressure

By Hana Yamamoto AAL
American Airlines Q4 Results Miss Estimates as Government Shutdown Cuts Revenue
AAL

American Airlines reported adjusted diluted EPS of $0.16 for the fourth quarter of 2025, missing multiple analyst forecasts and seeing revenue and unit metrics pressured by a government shutdown that the company said reduced top-line revenue by $325 million. While premium product revenue outperformed main cabin results and management provided upbeat fiscal 2026 guidance, analysts and data services trimmed near-term earnings estimates and flagged declines in unit revenue and margins.

Key Points

  • Adjusted diluted EPS of $0.16 for Q4 2025 missed multiple analyst forecasts cited in research coverage.
  • Government shutdown reduced top-line revenue by $325 million; domestic PRASM declined 2.5% year-over-year.
  • Premium product revenue outperformed main cabin unit revenue even as unit revenue fell 2% and total unit costs rose 4%.

American Airlines reported adjusted diluted earnings per share of $0.16 for the fourth quarter of 2025, a result that came in well below several analyst projections and drew attention to the financial impact of a recent government shutdown.

According to a Bernstein SocGen Group note cited in research coverage, the $0.16 adjusted EPS compared with an analyst expectation of $0.34, a sizable shortfall. Elsewhere in market reporting, the quarter was characterized as a 57.89% negative surprise relative to a $0.38 consensus forecast noted in company commentary, and the figure also trailed Evercore ISI’s estimate of $0.20 and the broader Street expectation of $0.36.

The company’s quarterly revenue totaled $14.00 billion, narrowly under the $14.04 billion that had been anticipated. Management said the government shutdown reduced top-line revenue by $325 million, a direct hit that analysts pointed to when revising near-term estimates. InvestingPro data referenced in research coverage indicated 10 analysts have trimmed earnings projections for the upcoming period.


Operational and unit metrics

Unit revenue and cost trends reflected the quarter’s pressure. American reported a 2% year-over-year drop in unit revenue while total unit costs rose 4% compared with the prior-year period. Separately, passenger revenue per available seat mile (PRASM) for domestic operations declined 2.5% year-over-year, a segment effect the Bernstein SocGen note said would have shown year-over-year growth absent the shutdown impact.

Profitability measures also weakened. The airline’s pre-tax margin for the quarter fell to 1%, down from 6% in the same period of 2024. Gross profit margin for the period was reported at 23.73%.


Revenue trends and recent growth

Despite the quarterly setback, American’s trailing-12-month revenue stood at $54.29 billion, representing modest growth of 1.27% over the prior twelve months. The research coverage underscored that premium cabin and other premium product offerings continued to outperform main cabin unit revenue during the quarter, marking a relative bright spot amid otherwise softer results.


Analyst reactions and price targets

Bernstein SocGen analyst David Vernon maintained an Outperform rating on American Airlines and kept a $20.00 price target despite the earnings miss. That target implies upside from the trading price cited in the research note of $13.55. InvestingPro commentary noted the current quoted price and labeled the stock undervalued relative to that target.

Evercore ISI retained an In Line rating for the company and kept a $17.00 price target. The broader set of analyst expectations cited in market reporting produced a range of estimates for the quarter, with the reported $0.16 EPS coming in below several of those figures.


Outlook and forecasts

The Bernstein SocGen research note pointed to strong fiscal year 2026 guidance from the company, framing the shutdown-related disruptions as potentially temporary rather than indicative of prolonged weakness. At the same time, InvestingPro forecasts flagged an expected drop in net income for the current year and projected EPS for fiscal 2025 of $0.56.

These competing signals - an earnings miss and weakened margins on one hand, and continued strength in premium products plus positive guidance for the next fiscal year on the other - shaped analyst commentary and investor interpretation of the quarter.


Key takeaways

  • American Airlines reported adjusted diluted EPS of $0.16 for Q4 2025, missing multiple analyst forecasts cited in research coverage.
  • The company said a government shutdown reduced revenue by $325 million; domestic PRASM fell 2.5% year-over-year.
  • Premium product revenues outperformed main cabin unit revenue, while unit revenue declined and unit costs rose.

Context for markets

The quarter’s results and accompanying analyst reactions have implications across airline equities, travel-related services, and sectors sensitive to consumer travel demand and fuel and labor cost dynamics. Revenue and margin pressure at a large carrier can ripple through supplier and distribution networks while influencing relative valuations within the airline peer group.

Risks

  • Near-term earnings revisions - InvestingPro data show 10 analysts recently lowered earnings estimates, increasing forecast uncertainty for the airline sector.
  • Margin pressure - Pre-tax margin declined to 1% from 6% year-over-year, and rising unit costs could tighten profitability across the airline and travel services sectors.
  • Revenue vulnerability to external disruptions - The $325 million revenue impact from a government shutdown demonstrates exposure of airline revenues to episodic policy or operational interruptions.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026